Elutia (ELUT) Insider Report: 12,500 RSUs Vest for Chief Scientific Officer
Rhea-AI Filing Summary
Elutia Inc. (ELUT) Chief Scientific Officer Michelle LeRoux Williams reported the vesting of restricted stock units on 09/10/2025 that resulted in the acquisition of 12,500 shares of Class A common stock. The filing shows 3,950 shares were withheld to satisfy tax withholding, leaving the reporting person with 97,335 shares beneficially owned after the transaction. The underlying RSU grant of 150,000 was originally made on January 31, 2024, with a defined multi-quarter vesting schedule through December 10, 2026.
Positive
- 12,500 shares vested from restricted stock units on 09/10/2025, increasing the reporting person's beneficial ownership
- Timely disclosure of the vesting and tax-withholding transaction consistent with Section 16 reporting requirements
Negative
- 3,950 shares withheld to satisfy tax obligations, reducing the net shares received
- No evidence in this filing of additional purchases that would further increase insider ownership beyond scheduled vesting
Insights
TL;DR: Routine RSU vesting increased insider ownership by 12,500 shares; modest net gain after tax withholding.
The reported transactions are non-derivative and arise from the scheduled vesting of previously granted restricted stock units. The officer received 12,500 shares on 09/10/2025 and had 3,950 shares withheld for taxes, resulting in 97,335 shares owned post-transaction. This is a standard compensation event that modestly increases insider alignment with shareholders but is not a market-moving issuance by itself.
TL;DR: Governance appears standard: time-based RSU award vesting with tax withholding, disclosed per Section 16 rules.
The Form 4 disclosure is complete for the reported vesting date and tax withholding, and it ties back to a 150,000 RSU grant on January 31, 2024 with scheduled vesting through December 2026. This follows typical executive equity compensation and timely Section 16 reporting, supporting transparency on insider ownership changes.
FAQ
What transaction did ELUT insider Michelle LeRoux Williams report on Form 4?
How many shares did Michelle LeRoux Williams own after the reported transaction?
Were any shares withheld for taxes in the Form 4 filing for ELUT?
What grant do the vested shares relate to?
Does this Form 4 indicate any option exercises or derivative transactions?